Regulus Therapeutics' Series A Round

Regulus Therapeutics raised a round of funding on March 06, 2009.

Regulus Therapeutics (NASDAQ: RGLS), a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. The Company uses…

Articles about Regulus Therapeutics' Series A Round: